Short-term and long-term outcomes of submucosal dissection for residual or recurrent colorectal tumors after endoscopic resection: Analysis of a multicenter prospective study.
endoscopic submucosal dissection
recurrent colorectal tumor
residual colorectal tumor
Journal
Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society
ISSN: 1443-1661
Titre abrégé: Dig Endosc
Pays: Australia
ID NLM: 9101419
Informations de publication
Date de publication:
26 Dec 2023
26 Dec 2023
Historique:
received:
27
06
2023
accepted:
25
12
2023
medline:
27
12
2023
pubmed:
27
12
2023
entrez:
26
12
2023
Statut:
aheadofprint
Résumé
We previously demonstrated that a favorable long-term prognosis indicated that endoscopic submucosal dissection (ESD) could be the standard treatment for large colorectal epithelial neoplasms, but the usefulness of ESD for local residual or recurrent tumors with submucosal fibrosis has not been fully demonstrated. The aim of the present study was to assess the usefulness of ESD for local residual or recurrent colorectal tumors. We conducted a nationwide multicenter prospective study to evaluate the outcomes of ESD for colorectal tumors. In this post-hoc analysis, a total of 54 local residual or recurrent colorectal tumors in 54 patients were included, and we analyzed the short-term and long-term outcomes of ESD for these lesions. The median size of the lesions was 16.0 (IQR;11-25) mm. ESD was completed in 53 cases (98.1%) with a median procedure time of 65.0 min, but it was discontinued in one case due to submucosal cancer invasion. En-bloc resection was achieved in 52 cases (96.3%), while R0 resection was achieved in 45 cases (83.3%). Intraoperative perforation was observed in 4 cases (7.4%) and delayed perforation in 1 case (1.9%), but all cases could be managed conservatively. Delayed bleeding was not observed. There were no significant differences in short-term outcomes between the rectal and colonic lesions. There was no recurrence of the tumor during the median follow-up period of 60 months (IQR 50-64). An analysis of our multicenter prospective study suggests that ESD is an effective salvage management for local residual or recurrent colorectal lesions.
Sections du résumé
BACKGROUND
BACKGROUND
We previously demonstrated that a favorable long-term prognosis indicated that endoscopic submucosal dissection (ESD) could be the standard treatment for large colorectal epithelial neoplasms, but the usefulness of ESD for local residual or recurrent tumors with submucosal fibrosis has not been fully demonstrated. The aim of the present study was to assess the usefulness of ESD for local residual or recurrent colorectal tumors.
METHODS
METHODS
We conducted a nationwide multicenter prospective study to evaluate the outcomes of ESD for colorectal tumors. In this post-hoc analysis, a total of 54 local residual or recurrent colorectal tumors in 54 patients were included, and we analyzed the short-term and long-term outcomes of ESD for these lesions.
RESULTS
RESULTS
The median size of the lesions was 16.0 (IQR;11-25) mm. ESD was completed in 53 cases (98.1%) with a median procedure time of 65.0 min, but it was discontinued in one case due to submucosal cancer invasion. En-bloc resection was achieved in 52 cases (96.3%), while R0 resection was achieved in 45 cases (83.3%). Intraoperative perforation was observed in 4 cases (7.4%) and delayed perforation in 1 case (1.9%), but all cases could be managed conservatively. Delayed bleeding was not observed. There were no significant differences in short-term outcomes between the rectal and colonic lesions. There was no recurrence of the tumor during the median follow-up period of 60 months (IQR 50-64).
CONCLUSION
CONCLUSIONS
An analysis of our multicenter prospective study suggests that ESD is an effective salvage management for local residual or recurrent colorectal lesions.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
This article is protected by copyright. All rights reserved.